Skip to content

HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention

HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01626898
Enrollment
304
Registered
2012-06-25
Start date
2012-08-31
Completion date
2015-08-31
Last updated
2016-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Risk Reduction Behavior

Brief summary

Wake Forest University is partnering with Chatham Social Health Council (a community-based organization) to conduct a randomized controlled trial to evaluate the efficacy of Hombres Ofreciendo Liderazgo y Apoyo (HOLA) en Grupos (Men Giving Leadership and Support in Groups), a Spanish-language HIV risk behavior intervention for Latino men who have sex with men (MSM) in rural North Carolina. Participants in the HOLA intervention, when compared to those in the comparison intervention, will report: increased consistent use of condoms during sexual intercourse; increased use of HIV and sexually transmitted disease (STD) counseling, testing, and treatment services; greater knowledge concerning the impact of HIV on communities (including Latino and MSM)and HIV risk behaviors and prevention strategies; more positive attitudes towards abstinence and condom use; increased self-efficacy to use and assert the use of condoms with sex partners; increased condom-use mastery scores; decreased barriers to risk reduction (e.g. health-compromising aspects of machismo); and enhanced partner and provider communication and sexual negotiation skills.

Detailed description

Wake Forest University is partnering with Chatham Social Health Council to conduct a randomized controlled trial to evaluate the efficacy of Hombres Ofreciendo Liderazgo y Apoyo (HOLA) en Grupos (Men Giving Leadership and Support in Groups) HIV risk behavior intervention for Latino men who have sex with men (MSM), ages 18 and over, in rural North Carolina. The Spanish language HOLA en Grupos was developed by the Chatham Social Health Council in close collaboration and partnership with the local Latino community, including Latino MSM, and representatives from a local community-based participatory research (CBPR) partnership that has been in existence for nearly ten years, and has been delivered by the Council to Latino MSM in an area the includes 6 largely rural counties for two years. HOLA en Grupos consists of four 4-hour group sessions that combine presentations by facilitators who are trained Latino MSM community members, activities, and scenes from a DVD, and is delivered over a period of two weeks to groups of about 10 participants. HOLA en Grupos was designed to increase HIV prevention knowledge, condom use and mastery, decrease barriers to risk reduction (e.g., health-compromising aspects of machismo), enhance sexual negotiation skills, and increase use of HIV testing, counseling, and treatment services among intervention participants. The Spanish language comparison condition consists of four 4-hour group sessions designed to increase participants' knowledge about cancer, diabetes, alcohol abuse, and cardiovascular disease, and is delivered over a period of two weeks to groups of about 10 participants. The content focus of the comparison condition reflects the desire of community partners to provide this type of information to community members. A total of 300 Latino MSM (150 per condition) will be screened and if eligible, recruited in waves of 20 men (10 per condition). Eligible individuals must self-identify as Latino or Hispanic, be ≥ 18 years of age, report MSM behavior since age ≥ 18, and provide informed consent. Individuals who have participated in the HOLA en Grupos, or interventions for Latino heterosexual men (HoMBReS or HoMBReS-2), will be excluded from the study. Study assessments will be conducted at baseline and 6-month follow-up.

Interventions

BEHAVIORALHOLA en Grupos

HOLA en Grupos consists of four 4-hour group sessions that combine presentations by facilitators who are trained Latino MSM community members, activities, and scenes from a DVD, and is delivered over a period of two weeks to groups of about 10 participants. HOLA en Grupos is designed to increase HIV prevention knowledge, condom use and mastery, decrease barriers to risk reduction (e.g., health-compromising aspects of machismo), enhance sexual negotiation skills, and increase use of HIV testing, counseling, and treatment services among intervention participants.

BEHAVIORALGeneral Health intervention (comparison intervention )

The Spanish comparison condition consists of four Spanish-language 4-hour group sessions designed to increase participants' knowledge about cancer, diabetes, alcohol abuse, and cardiovascular disease, and is delivered over a period of two weeks to groups of about 10 participants.

Sponsors

Centers for Disease Control and Prevention
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male gender * Self-identify as Latino or Hispanic * 18 years of age or older * Speak Spanish * Have had sex with another man since attaining age 18 * Have not participated in HOLA, HOLA en Grupos, HoMBReS or other Latino Partnership interventions developed and delivered by the Chatham Social Health Council or Wake Forest University during the past 12 months

Exclusion criteria

* Have had sex with at least one woman since attaining age 18 but who have not had sex with at least one man since attaining age 18

Design outcomes

Primary

MeasureTime frame
Increased self-reported consistent use of condoms during sexual intercourse6 months post-intervention

Secondary

MeasureTime frame
Increased self-reported use of HIV and sexually transmitted disease (STD) counseling, testing, and treatment services6 months post-intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026